Jiangsu Hengrui Medicine
600276.SS
#509
Rank
โ‚ฌ36.55 B
Marketcap
5,73ย โ‚ฌ
Share price
-0.27%
Change (1 day)
0.35%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of June 2024 : โ‚ฌ5.36 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company has โ‚ฌ5.36 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2022-12-31$โ‚ฌ5.19 B5.82%
2021-12-31$โ‚ฌ4.90 B27.07%
2020-12-31$โ‚ฌ3.86 B21.46%
2019-12-31$โ‚ฌ3.17 B25.7%
2018-12-31$โ‚ฌ2.52 B23.83%
2017-12-31$โ‚ฌ2.04 B15.87%
2016-12-31$โ‚ฌ1.76 B20.41%
2015-12-31$โ‚ฌ1.46 B35.32%
2014-12-31$โ‚ฌ1.08 B35.88%
2013-12-31$โ‚ฌ0.79 B20.54%
2012-12-31$โ‚ฌ0.66 B23.11%
2011-12-31$โ‚ฌ0.53 B35.44%
2010-12-31$โ‚ฌ0.39 B45.33%
2009-12-31$โ‚ฌ0.27 B29.4%
2008-12-31$โ‚ฌ0.21 B36.82%
2007-12-31$โ‚ฌ0.15 B25.1%
2006-12-31$โ‚ฌ0.12 B6.13%
2005-12-31$โ‚ฌ0.11 B45.19%
2004-12-31$โ‚ฌ79.85 M-8.71%
2003-12-31$โ‚ฌ87.47 M-6.55%
2002-12-31$โ‚ฌ93.61 M-9.73%
2001-12-31$โ‚ฌ0.10 B